Search results
VFW baseball: Willmar brings home a couple more wins
West Central Tribune, Willmar, Minn.· 3 days agoJul. 8—WILLMAR — The Willmar VFW baseball team is cruising. With a doubleheader sweep over Marshall Black on Monday at Elsie Klemmetson Field, Post 1639 has won five straight games. It earned ...
Eli Lilly weight loss drug beats Ozempic in head-to-head study - ET HealthWorld | Pharma
The Economic Times· 3 days agoWashington: Patients taking Eli Lilly's new drug Mounjaro achieved significantly greater weight loss...
Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal, says report - CNBC TV18
CNBC TV18· 3 days agoLilly counts its IBD drug, Omvoh, among its future growth drivers, besides its blockbuster weight...
'Compounded' weight-loss drugs are a growing problem for state regulators
Stateline.org· 3 days agoJul. 8—Anna Wysock's "aha" moment arrived in an Ohio amusement park, as she got ready to ride a roller coaster with her 7-year-old son: The safety bar across her lap would only click into place ...
Lilly bolsters IBD portfolio with $3.2bn Morphic acquisition
Pharmaceutical Technology· 3 days agoEli Lilly has signed a definitive agreement to acquire Morphic Holding for $3.2bn, expanding its...
Locos stumble in series finale against Xenia
The Lima News, Ohio· 3 days agoJul. 8—LIMA — Xenia starting pitcher Brenden Holland (Lourdes University) has had the Locos number this season. The 5-11 lefty from Riga, Michigan has two wins as a starter, both coming at Simmons ...
Eli Lilly to buy bowel disease drug developer Morphic for $3.2 bln - ET HealthWorld | Pharma
The Economic Times· 3 days agoLondon: Eli Lilly will acquire Morphic Holding for $3.2 billion in cash, the companies said on...
Lilly to buy Morphic in $3B bet on inflammation drug
BioPharma Dive· 3 days agoThe deal would hand Lilly an experimental pill that could one day rival Takeda's blockbuster medicine Entyvio as a treatment for inflammatory bowel...
A London biotech raises $114M to hone a new ADC payload
BioPharma Dive· 3 days agoInvestors Novo Holdings and Abingworth co-led its Series A, with participation from British Patient...
Myricx Bio gains $114m in Series A round to develop NMTi-ADCs
Pharmaceutical Technology· 4 days agoThe capital injection will be channelled into expanding Myricx’s NMTi inhibitor ADC payload...